This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More!
This week in psychedelic stock news, there are big patent developments for Compass, MindMed and Numinus.
Day: June 24, 2022
Compass Pathways Psilocybin Patent Upheld
Compass Pathways scores a major victory in their bid to patent Comp 360, a proprietary formulation of psilocybin.
End of content
End of content